ArticleBMC cancer2020

Distinct mutation profiles between primary bladder cancer and circulating tumor cells warrant the use of circulating tumors cells as cellular resource for mutation follow-up.

Tae-Min Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.